Inorganic nanoparticle-based contrast agents for molecular imaging.
暂无分享,去创建一个
Younan Xia | Michael J Welch | Jingyi Chen | M. Welch | Younan Xia | E. Cho | Jingyi Chen | Charles Glaus | Eun Chul Cho | Charles Glaus
[1] Pai-Chi Li,et al. In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. , 2008, Optics express.
[2] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[3] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[4] P. Reimer,et al. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.
[5] Sanjiv S. Gambhir,et al. Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.
[6] Grace Hu,et al. Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.
[7] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[8] Anna Moore,et al. In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe , 2004, Cancer Research.
[9] Tumor imaging using P866, a high‐relaxivity gadolinium chelate designed for folate receptor targeting , 2008, Magnetic resonance in medicine.
[10] Zhen Cheng,et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. , 2010, Small.
[11] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[12] Xiaoyuan Chen,et al. Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Mitsuo Komatsu,et al. Organic reactions on silica in water. , 2009, Chemical reviews.
[14] Xiaohu Gao,et al. Plasmonic fluorescent quantum dots. , 2009, Nature nanotechnology.
[15] Dai Fukumura,et al. InAs(ZnCdS) quantum dots optimized for biological imaging in the near-infrared. , 2009, Journal of the American Chemical Society.
[16] Anna Moore,et al. In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy , 2006, International journal of cancer.
[17] N. K. Prasad,et al. Mechanism of cell death induced by magnetic hyperthermia with nanoparticles of γ-MnxFe2–xO3 synthesized by a single step process , 2007 .
[18] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[19] Yusuf Emre Erdi,et al. The Use of PET for Radiotherapy , 2007 .
[20] Kai Chen,et al. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Ralph Weissleder,et al. Detection of early prostate cancer using a hepsin-targeted imaging agent. , 2008, Cancer research.
[22] Ji-Ho Park,et al. Cooperative nanomaterial system to sensitize, target, and treat tumors , 2009, Proceedings of the National Academy of Sciences.
[23] I. Lucet,et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.
[24] P. Jacobs,et al. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[25] Robert Sinclair,et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.
[26] Jinwoo Cheon,et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.
[27] Raoul Kopelman,et al. Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.
[28] S Vajda,et al. Effect of conformational flexibility and solvation on receptor-ligand binding free energies. , 1994, Biochemistry.
[29] Jin-Sil Choi,et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.
[30] T. Quinn,et al. 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging. , 2008, Bioconjugate chemistry.
[31] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[32] Steven R. Emory,et al. Probing Single Molecules and Single Nanoparticles by Surface-Enhanced Raman Scattering , 1997, Science.
[33] J. Folkman,et al. Fighting cancer by attacking its blood supply. , 1996, Scientific American.
[34] Robert Sinclair,et al. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. , 2008, Nano letters.
[35] G. Whitesides,et al. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.
[36] Wolfhard Semmler,et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. , 2007, Cancer research.
[37] Feng Gao,et al. In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.
[38] Sanjiv S Gambhir,et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.
[39] Thomas A. Klar,et al. Plasmon emission in photoexcited gold nanoparticles , 2004 .
[40] Vincent Noireaux,et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.
[41] D. Leslie-Pelecky,et al. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. , 2008, Molecular pharmaceutics.
[42] Shuming Nie,et al. Semiconductor nanocrystals: structure, properties, and band gap engineering. , 2010, Accounts of chemical research.
[43] Vladimir P Zharov,et al. Quantum dots as multimodal photoacoustic and photothermal contrast agents. , 2008, Nano letters.
[44] Anke M Hövels,et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. , 2008, The Lancet. Oncology.
[45] Vincent M Rotello,et al. Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.
[46] Ralph Weissleder,et al. Long-circulating iron oxides for MR imaging , 1995 .
[47] J. Bünzli. Lanthanide luminescence for biomedical analyses and imaging. , 2010, Chemical reviews.
[48] Younan Xia,et al. Bright three-photon luminescence from gold/silver alloyed nanostructures for bioimaging with negligible photothermal toxicity. , 2010, Angewandte Chemie.
[49] B. Kaufmann. Ultrasound Molecular Imaging of Cardiovascular Disease , 2010 .
[50] D. A. Capretto,et al. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. , 2008, Cancer biotherapy & radiopharmaceuticals.
[51] May D. Wang,et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.
[52] D. Elder,et al. Integrin Distribution in Malignant Melanoma : Association of the ß 3 Subunit with Tumor Progression 1 , 2006 .
[53] John T Fourkas,et al. Highly efficient multiphoton-absorption-induced luminescence from gold nanoparticles. , 2005, Nano letters.
[54] Jeffrey J. Gray,et al. The interaction of proteins with solid surfaces. , 2004, Current opinion in structural biology.
[55] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[56] M. Wendland,et al. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents , 2008, Pediatric Radiology.
[57] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[58] Younan Xia,et al. Measuring the Optical Absorption Cross-sections of Au-Ag Nanocages and Au Nanorods by Photoacoustic Imaging. , 2009, The journal of physical chemistry. C, Nanomaterials and interfaces.
[59] F. Marshall,et al. In vivo molecular and cellular imaging with quantum dots. , 2005, Current opinion in biotechnology.
[60] 星野 昭芳,et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification , 2008 .
[61] Ralph Weissleder,et al. Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.
[62] Shuming Nie,et al. Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. , 2006, Analytical chemistry.
[63] Noriaki Ohuchi,et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. , 2007, Cancer research.
[64] D. Elder,et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.
[65] C. Haynes,et al. Globular proteins at solid/liquid interfaces , 1994 .
[66] R. Bellamkonda,et al. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. , 2009, Radiology.
[67] Nathan Kohler,et al. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.
[68] A. Estrada,et al. Two-photon-induced photoluminescence imaging of tumors using near-infrared excited gold nanoshells , 2008, 2008 Conference on Lasers and Electro-Optics and 2008 Conference on Quantum Electronics and Laser Science.
[69] Hui Zhang,et al. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. , 2005, Nano letters.
[70] K. Licha. Contrast Agents for Optical Imaging , 2002 .
[71] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[72] Michael J Sailor,et al. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.
[73] Simon R. Cherry,et al. PET: Physics, Instrumentation, and Scanners , 2006 .
[74] Antony K. Chen,et al. Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.
[75] Younan Xia,et al. Gold nanocages as photothermal transducers for cancer treatment. , 2010, Small.
[76] Younan Xia,et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light , 2009, Nature materials.
[77] E. Beaurepaire,et al. Functionalized fluorescent oxide nanoparticles: Artificial toxins for sodium channel targeting and imaging at the single-molecule level , 2004 .
[78] J. Fujimoto,et al. Optical biopsy and imaging using optical coherence tomography , 1995, Nature Medicine.
[79] Ron C. Hardman. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.
[80] Michael J Sailor,et al. Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.
[81] Xinmai Yang,et al. Nanoparticles for photoacoustic imaging. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[82] Michael J Sailor,et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. , 2009, Cancer research.
[83] Francis Vocanson,et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[84] J F Hainfeld,et al. Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.
[85] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[86] R. Robb. X-ray computed tomography: from basic principles to applications. , 1982, Annual review of biophysics and bioengineering.
[87] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[88] K. Nicolay,et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. , 2006, Bioconjugate chemistry.
[89] Raoul Kopelman,et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.
[90] Susan Newbigging,et al. In vivo quantum-dot toxicity assessment. , 2010, Small.
[91] Shimon Weiss,et al. Synthesis and Properties of Biocompatible Water-Soluble Silica-Coated CdSe/ZnS Semiconductor Quantum Dots† , 2001 .
[92] M. Wendland,et al. MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. , 2007, Contrast media & molecular imaging.
[93] Yun Sun,et al. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. , 2010, Biomaterials.
[94] Xueding Wang,et al. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[95] Shelton D Caruthers,et al. Magnetic resonance molecular imaging with nanoparticles , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[96] W. Deen,et al. Structural determinants of glomerular permeability. , 2001, American journal of physiology. Renal physiology.
[97] V. Hruby,et al. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. , 1990, The Biochemical journal.
[98] Michael J. Welch,et al. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.
[99] Naomi J Halas,et al. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.
[100] P. Perriat,et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.
[101] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[102] Younan Xia,et al. Superparamagnetic Colloids: Controlled Synthesis and Niche Applications , 2007 .
[103] Younan Xia,et al. Modifying the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles through A Sol−Gel Approach , 2002 .
[104] S. Gambhir,et al. Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging. , 2005, Cancer research.
[105] Atle Bjørnerud,et al. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging , 2004, Cell and Tissue Research.
[106] K. Fujita. [Two-photon laser scanning fluorescence microscopy]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[107] G. Whitesides,et al. Effect of Surface Wettability on the Adsorption of Proteins and Detergents , 1998 .
[108] Alaaldin M. Alkilany,et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. , 2008, Accounts of chemical research.
[109] Dong Liang,et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.
[110] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[111] W. Bradley,et al. MRI: The Basics , 1997 .
[112] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[113] Chenjie Xu,et al. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.
[114] Elena V. Shevchenko,et al. Gold/Iron Oxide Core/Hollow‐Shell Nanoparticles , 2008 .
[115] Younan Xia,et al. Gold Nanocages: Synthesis, Properties, and Applications , 2009 .
[116] M. V. van Zandvoort,et al. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. , 2008, Cancer research.
[117] Sanjiv S. Gambhir,et al. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy , 2009, Proceedings of the National Academy of Sciences.
[118] A. Alivisatos. Perspectives on the Physical Chemistry of Semiconductor Nanocrystals , 1996 .
[119] T. Meade,et al. Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging , 2009, MRS bulletin.
[120] J. Willmann,et al. Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET , 2008, Journal of Nuclear Medicine.
[121] B. Haraldsson,et al. A gel-membrane model of glomerular charge and size selectivity in series. , 2001, AJP - Renal Physiology.
[122] W Semmler,et al. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.
[123] Tymish Y. Ohulchanskyy,et al. High contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors. , 2008, Nano letters.
[124] Samuel Achilefu,et al. Introduction to concepts and strategies for molecular imaging. , 2010, Chemical reviews.
[125] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[126] S. Nie,et al. Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.